{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:38:43Z","timestamp":1776688723790,"version":"3.51.2"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,10,15]]},"DOI":"10.18632\/oncotarget.2362","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:37:56Z","timestamp":1442360276000},"page":"9133-9149","source":"Crossref","is-referenced-by-count":25,"title":["p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin\/\u03b21 integrin signaling activation"],"prefix":"10.18632","volume":"5","author":[{"given":"Carman Ka","family":"Man Ip","sequence":"first","affiliation":[{"name":"School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Yung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Sassoon Road, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak-Mao","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Sassoon Road, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai-Wah","family":"Tsao","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Hong Kong, Sassoon Road, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Sze","family":"Tsai Wong","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2014,8,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Jemal","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14728222.2012.684680","article-title":"Exploiting p70 S6 kinase as a target for ovarian cancer","volume":"16","author":"Wong","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"3","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","article-title":"AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth","volume":"23","author":"Testa","year":"2004","journal-title":"Oncogene"},{"key":"4","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/en.2005-1404","article-title":"Activation of p70(S6K) induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells","volume":"147","author":"Wong","year":"2006","journal-title":"Endocrinology"},{"key":"5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cncr.22195","article-title":"Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer","volume":"107","author":"Cajal","year":"2006","journal-title":"Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1158\/0008-5472.CAN-07-6302","article-title":"p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells","volume":"68","author":"Wong","year":"2008","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(03)00068-6","article-title":"Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule","volume":"202","author":"Sundfeldt","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-0-387-98094-2_14","article-title":"Cell adhesion in ovarian cancer","volume":"149","author":"Kohn","year":"2009","journal-title":"Cancer Treat Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<476::AID-IJC7>3.0.CO;2-V","article-title":"Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells","volume":"83","author":"Smith","year":"1999","journal-title":"Int J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Lengyel","year":"2007","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.onc.1204253","article-title":"Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?","volume":"20","author":"Auersperg","year":"2001","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexcr.2004.06.002","article-title":"Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation","volume":"299","author":"Auersperg","year":"2004","journal-title":"Exp Cell Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.0.CO;2-4","article-title":"Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin","volume":"67","author":"Stack","year":"1996","journal-title":"Int J Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/bjc.1989.186","article-title":"Mesothelial cells stimulate the anchorage-independent growth of human ovarian tumour cells","volume":"59","author":"Wilson","year":"1989","journal-title":"Br J Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1139\/o96-085","article-title":"Ligand binding and affinity modulation of integrins","volume":"74","author":"Loftus","year":"1996","journal-title":"Biochem Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbamem.2004.03.012","article-title":"Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins","volume":"1663","author":"Bellis","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"18","doi-asserted-by":"crossref","first-page":"32830","DOI":"10.1074\/jbc.M202493200","article-title":"Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors","volume":"277","author":"Bellis","year":"2002","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1206834","article-title":"Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin","volume":"22","author":"Bellis","year":"2003","journal-title":"Oncogene"},{"key":"20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Vanderhyden","year":"2004","journal-title":"Mol Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/onc.2011.7","article-title":"P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin","volume":"30","author":"Wong","year":"2011","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm1699","article-title":"Regulation of cadherin-mediated adhesion in morphogenesis","volume":"6","author":"Gumbiner","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0955-0674(95)80102-2","article-title":"Morphogenetic roles of classic cadherins","volume":"7","author":"Takeichi","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"24","first-page":"685","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Skubitz","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"25","first-page":"2185","article-title":"Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary","volume":"21","author":"Kohlberger","year":"2001","journal-title":"Anticancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Lengyel","year":"2011","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/onc.2009.523","article-title":"Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer","volume":"29","author":"Wong","year":"2010","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0898-6568(97)00074-0","article-title":"Integrin-mediated adhesion and signalling in ovarian cancer cells","volume":"10","author":"Hasan","year":"1998","journal-title":"Cell Signal"},{"key":"29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/ncomms2560","article-title":"N-cadherin regulates spatially polarized signals through distinct p120ctn and beta-catenin-dependent signalling pathways","volume":"4","author":"Wang","year":"2013","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2443.2007.01092.x","article-title":"T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells","volume":"12","author":"Matsuyoshi","year":"2007","journal-title":"Genes Cells"},{"key":"31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0960-9822(03)00433-0","article-title":"Integrin-ECM interactions regulate cadherin-dependent cell adhesion and are required for convergent extension in Xenopus","volume":"13","author":"DeSimone","year":"2003","journal-title":"Curr Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1242\/jcs.047878","article-title":"Integrins stimulate E-cadherin-mediated intercellular adhesion by regulating Src-kinase activation and actomyosin contractility","volume":"123","author":"Dufour","year":"2010","journal-title":"J Cell Sci"},{"key":"33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.200312013","article-title":"Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion","volume":"166","author":"Sabe","year":"2004","journal-title":"J Cell Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbamem.2007.12.015","article-title":"Molecular components of the adherens junction","volume":"1778","author":"Gottardi","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1023\/A:1011077000164","article-title":"The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role","volume":"17","author":"Dall'Olio","year":"2000","journal-title":"Glycoconj J"},{"key":"36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/glycob\/2.1.49","article-title":"The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells","volume":"2","author":"Delannoy","year":"1992","journal-title":"Glycobiology"},{"key":"37","doi-asserted-by":"crossref","first-page":"20863","DOI":"10.1016\/S0021-9258(17)45295-1","article-title":"Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation","volume":"265","author":"Paulson","year":"1990","journal-title":"J Biol Chem"},{"key":"38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0300-9084(92)90188-K","article-title":"Comparison of sialyl- and alpha-1,3-galactosyltransferase activity in NIH3T3 cells transformed with ras oncogene: increased beta-galactoside alpha-2,6-sialyltransferase","volume":"74","author":"Delannoy","year":"1992","journal-title":"Biochimie"},{"key":"39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-1-3","article-title":"ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function","volume":"1","author":"Bellis","year":"2008","journal-title":"J Ovarian Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1023\/A:1022288022969","article-title":"Sialyltransferases in cancer","volume":"18","author":"Chiricolo","year":"2001","journal-title":"Glycoconj J"},{"key":"41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1757-2215-6-25","article-title":"ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells","volume":"6","author":"Bellis","year":"2013","journal-title":"J Ovarian Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1593\/neo.91438","article-title":"c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1\/2","volume":"12","author":"Wong","year":"2010","journal-title":"Neoplasia"},{"key":"43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mc.20315","article-title":"Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC)","volume":"46","author":"Mes-Masson","year":"2007","journal-title":"Mol Carcinog"},{"key":"44","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","article-title":"RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model","volume":"13","author":"Testa","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"45","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-06-4490","article-title":"RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer","volume":"67","author":"Testa","year":"2007","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10147-010-0177-z","article-title":"Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases","volume":"16","author":"Aoki","year":"2011","journal-title":"International journal of clinical oncology"},{"key":"47","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1158\/1078-0432.CCR-10-2289","article-title":"Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma","volume":"17","author":"Dorigo","year":"2011","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"48","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1158\/1535-7163.MCT-07-0237","article-title":"Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer","volume":"6","author":"Soo","year":"2007","journal-title":"Molecular cancer therapeutics"},{"key":"49","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.18632\/oncotarget.1834","article-title":"Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus","volume":"5","author":"Kurzrock","year":"2014","journal-title":"Oncotarget"},{"key":"50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/aging.100496","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53\u2212\/\u2212 mice by delaying carcinogenesis","volume":"4","author":"Antoch","year":"2012","journal-title":"Aging"},{"key":"51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18632\/aging.100498","article-title":"Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+\/\u2212 mice","volume":"4","author":"Gudkov","year":"2012","journal-title":"Aging"},{"key":"52","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4161\/cbt.26947","article-title":"Dysregulation of the mTOR pathway in p53-deficient mice","volume":"14","author":"Blagosklonny","year":"2013","journal-title":"Cancer biology & therapy"},{"key":"53","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy","volume":"153","author":"Bast","year":"2012","journal-title":"Endocrinology"},{"key":"54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Brugge","year":"2011","journal-title":"Cancer Discov"},{"key":"55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/089686080602600207","article-title":"Peritoneal mesothelial cell culture and biology","volume":"26","author":"Chan","year":"2006","journal-title":"Perit Dial Int"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T17:24:30Z","timestamp":1748625870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,21]]},"references-count":55,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,10,15]]}},"alternative-id":["2362","25193855"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2362","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,21]]}}}